Symeonides, S., Evans, J., Arkenau, H.-T., McKean, M., Lakhani, N., Lim, E., Falchook, G., Rotolo, J., Capiaux, G., Michel, R., Kaesshaefer, S., & Bexon, A. (2021). CTNI-49. PHASE 1 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN ß, IN PATIENTS WITH ADVANCED SOLID TUMORS, WITH A PHASE 2 EXPANSION IN RECURRENT GLIOBLASTOMA MULTIFORME. Neuro-Oncology, 23(Supplement_6), vi71–vi71. https://doi.org/10.1093/neuonc/noab196.274